Intramyocardial Injection of Autologous Bone Marrow Mononuclear Cells in Patients With Chronic Myocardial Infarction and Severe Left Ventricular Dysfunction

American Journal of Cardiology

Volumn 100, Issue 7, 2007, Pages 1094-1098

  Beeres, Saskia L M A ^a   Bax, Jeroen J ^a   Dibbets Schneider, Petra ^a   Stokkel, Marcel P M ^a   Fibbe, Willem E ^a   van der Wall, Ernst E ^a   Schalij, Martin J ^a   Atsma, Douwe E ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACIPIMOX; ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FLUORODEOXYGLUCOSE F 18; SPIRONOLACTONE; TETROFOSMIN TC 99M;

ADULT; AGED; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; CHRONIC DISEASE; CLINICAL ARTICLE; CLINICAL PROTOCOL; DISEASE SEVERITY; FEMALE; FOLLOW UP; HEART INFARCTION; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE; HEART MUSCLE METABOLISM; HUMAN; HUMAN CELL; INJECTION; MALE; MONONUCLEAR CELL; MORTALITY; PATIENT SAFETY; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TREATMENT OUTCOME;

AGED; BONE MARROW TRANSPLANTATION; FEASIBILITY STUDIES; FEMALE; GLUCOSE; HUMANS; INJECTIONS; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION; MYOCARDIUM; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT;

EID: 34548653403     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2007.04.056     Document Type: Article

References (13)

1. Rector T.S., Kubo S.H., and Cohn J.N. Validity of the Minnesota Living with Heart Failure questionnaire as a measure of therapeutic response to enalapril or placebo. Am J Cardiol 71 (1993) 1106-1107
2. Perin E.C., Dohmann H.F., Borojevic R., Silva S.A., Sousa A.L., Mesquita C.T., Rossi M.I., Carvalho A.C., Dutra H.S., Dohmann H.J., et al. Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure. Circulation 107 (2003) 2294-2302
3. Perin E.C., Silva G.V., Sarmento-Leite R., Sousa A.L., Howell M., Muthupillai R., Lambert B., Vaughn W.K., and Flamm S.D. Assessing myocardial viability and infarct transmurality with left ventricular electromechanical mapping in patients with stable coronary artery disease: validation by delayed-enhancement magnetic resonance imaging. Circulation 106 (2002) 957-961
4. Beeres S.L., Bax J.J., Dibbets P., Stokkel M.P., Zeppenfeld K., Fibbe W.E., van der Wall E.E., Schalij M.J., and Atsma D.E. Effect of intramyocardial injection of autologous bone marrow-derived mononuclear cells on perfusion, function, and viability in patients with drug-refractory chronic ischemia. J Nucl Med 47 (2006) 574-580
5. Cerqueira M.D., Weissman N.J., Dilsizian V., Jacobs A.K., Kaul S., Laskey W.K., Pennell D.J., Rumberger J.A., Ryan T., and Verani M.S. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation 105 (2002) 539-542
6. Sharir T., Berman D.S., Waechter P.B., Areeda J., Kavanagh P.B., Gerlach J., Kang X., and Germano G. Quantitative analysis of regional motion and thickening by gated myocardial perfusion SPECT: normal heterogeneity and criteria for abnormality. J Nucl Med 42 (2001) 1630-1638
7. Schinkel A.F., Bax J.J., Valkema R., Elhendy A., van Domburg R.T., Vourvouri E.C., Bountioukos M.A., Krenning E.P., Roelandt J.R., and Poldermans D. Effect of diabetes mellitus on myocardial 18F-FDG SPECT using acipimox for the assessment of myocardial viability. J Nucl Med 44 (2003) 877-883
8. Knuuti M.J., Yki-Järvinen H., Voipio-Pulkki L.M., Mäki M., Ruotsalainen U., Härkönen R., Teräs M., Haaparanta M., Bergman J., Hartiala J., Wegelius U., and Nuutila P. Enhancement of myocardial [fluorine-18] fluorodeoxyglucose uptake by a nicotinic acid derivative. J Nucl Med 35 (1994) 989-998
9. Bax J.J., Veening M.A., Visser F.C., van Lingen A., Heine R.J., Cornel J.H., and Visser C.A. Optimal metabolic conditions during fluorine-18 fluorodeoxyglucose imaging; a comparative study using different protocols. Eur J Nucl Med 24 (1997) 35-41
10. Assmus B., Honold J., Schachinger V., Britten M.B., Fischer-Rasokat U., Lehmann R., Teupe C., Pistorius K., Martin H., Abolmaali N.D., et al. Transcoronary transplantation of progenitor cells after myocardial infarction. N Engl J Med 355 (2006) 1222-1232
11. Strauer B.E., Brehm M., Zeus T., Bartsch T., Schannwell C., Antke C., Sorg R.V., Kogler G., Wernet P., Muller H.W., and Kostering M. Regeneration of human infarcted heart muscle by intracoronary autologous bone marrow cell transplantation in chronic coronary artery disease: the IACT Study. J Am Coll Cardiol 46 (2005) 1651-1658
12. Wollert K.C., and Drexler H. Clinical applications of stem cells for the heart. Circ Res 96 (2005) 151-163
13. Boyle A.J., Schulman S.P., Hare J.M., and Oettgen P. Is stem cell therapy ready for patients? Stem cell therapy for cardiac repair. Ready for the next step. Circulation 114 (2006) 339-352